TWiV 843: COVID-19 clinical update #93 with Dr. Daniel Griffin
Dec 18, 2021•43 min•Ep. 843
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #93, Dr. Griffin summarizes Omicron fitness, S-gene target failure, monoclonal efficacy against Omicron, vaccination, monoclonals, and disease in children, persistence of memory B cells in the elderly, infection and vaccine induced immunity, protection against severe illness and death by a third mRNA vaccine dose, high flow oxygen versus intubation, and therapeutic anticoagulation.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Variant updates (CDC)
- List of diagnostic kits (Global Fund, pdf)
- B1.1.529 escapes most antibodies (bioRxiv)
- mRNA vaccine third dose and Omicron (medRxiv)
- Outpatient strategies children and adolescents (AAP)
- Memory B cells persist in elderly (J Clin Invest)
- mRNA booster effect against Delta (Clin Inf Dis)
- Azithromycin meta-analysis (J Antimicrob Chemo)
- High-flow oxygen vs intubation (JAMA)
- Therapeutic anticoagulation (Ann Int Med)
- Africa cases surge (CIDRAP)
- Letters read on TWiV 843
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android